BACKGROUND: Previous studies in mice showed that respiratory syncytial virus (RSV) infection was associated with RSV RNA persistence. This study was designed to characterize the significance of RSV RNA persistence and its relation to RSV-induced chronic airway disease. METHODS: Mice were inoculated with live RSV, UV light-treated RSV, heat-inactivated RSV, or medium. Bronchoalveolar lavage fluid samples were obtained and lung specimens were harvested on days 1, 5, and 42 after inoculation to assess lung inflammation, lung mRNA expression of interleukin (IL)-4, IL-5, IL-15, and interferon (IFN)-gamma; RSV loads were assessed by culture and real-time polymerase chain reaction (PCR) and correlated with pulmonary function. RESULTS: During the acute phase of infection, RSV loads as indicated by culture and PCR were significantly higher in mice inoculated with live RSV. On day 42, RSV RNA remained detectable only in mice inoculated with live or UV light-treated RSV. Lung inflammation, IFN-gamma:IL-4 mRNA expression ratios, airway obstruction (AO), and airway hyperreactivity (AHR) were significantly increased in mice inoculated with live RSV. AO on day 5 and AHR on day 42 were significantly correlated with RSV RNA copy number in lung samples. CONCLUSIONS: Infection with live RSV induced acute and chronic airway disease that was associated with a predominantly Th-1 immune response and RSV RNA persistence that significantly correlated with pulmonary function abnormalities.
BACKGROUND: Previous studies in mice showed that respiratory syncytial virus (RSV) infection was associated with RSV RNA persistence. This study was designed to characterize the significance of RSV RNA persistence and its relation to RSV-induced chronic airway disease. METHODS:Mice were inoculated with live RSV, UV light-treated RSV, heat-inactivated RSV, or medium. Bronchoalveolar lavage fluid samples were obtained and lung specimens were harvested on days 1, 5, and 42 after inoculation to assess lung inflammation, lung mRNA expression of interleukin (IL)-4, IL-5, IL-15, and interferon (IFN)-gamma; RSV loads were assessed by culture and real-time polymerase chain reaction (PCR) and correlated with pulmonary function. RESULTS: During the acute phase of infection, RSV loads as indicated by culture and PCR were significantly higher in mice inoculated with live RSV. On day 42, RSV RNA remained detectable only in mice inoculated with live or UV light-treated RSV. Lung inflammation, IFN-gamma:IL-4 mRNA expression ratios, airway obstruction (AO), and airway hyperreactivity (AHR) were significantly increased in mice inoculated with live RSV. AO on day 5 and AHR on day 42 were significantly correlated with RSV RNA copy number in lung samples. CONCLUSIONS:Infection with live RSV induced acute and chronic airway disease that was associated with a predominantly Th-1 immune response and RSV RNA persistence that significantly correlated with pulmonary function abnormalities.
Authors: T Seemungal; R Harper-Owen; A Bhowmik; I Moric; G Sanderson; S Message; P Maccallum; T W Meade; D J Jeffries; S L Johnston; J A Wedzicha Journal: Am J Respir Crit Care Med Date: 2001-11-01 Impact factor: 21.405
Authors: Berkeley L Bennett; Roberto P Garofalo; Stanley G Cron; Yashoda M Hosakote; Robert L Atmar; Charles G Macias; Pedro A Piedra Journal: J Infect Dis Date: 2007-04-12 Impact factor: 5.226
Authors: M J Mäkelä; A Kanehiro; L Borish; A Dakhama; J Loader; A Joetham; Z Xing; M Jordana; G L Larsen; E W Gelfand Journal: Proc Natl Acad Sci U S A Date: 2000-05-23 Impact factor: 11.205
Authors: S M van Schaik; N Obot; G Enhorning; K Hintz; K Gross; G E Hancock; A M Stack; R C Welliver Journal: J Med Virol Date: 2000-10 Impact factor: 2.327
Authors: R S Peebles; J R Sheller; R D Collins; A K Jarzecka; D B Mitchell; R A Parker; B S Graham Journal: J Med Virol Date: 2001-02 Impact factor: 2.327
Authors: Carrie C Smallcombe; Debra T Linfield; Terri J Harford; Vladimir Bokun; Andrei I Ivanov; Giovanni Piedimonte; Fariba Rezaee Journal: Am J Physiol Lung Cell Mol Physiol Date: 2018-11-29 Impact factor: 5.464
Authors: Richard Bannister; Deborah Rodrigues; Edward J Murray; Carl Laxton; Mike Westby; Helen Bright Journal: Virol J Date: 2010-09-22 Impact factor: 4.099
Authors: Juan Pablo Torres; Ana M Gomez; Shama Khokhar; Vijay G Bhoj; Claudia Tagliabue; Michael L Chang; Peter A Kiener; Paula A Revell; Octavio Ramilo; Asuncion Mejias Journal: Respir Res Date: 2010-09-15
Authors: Cesar Mella; M Carmen Suarez-Arrabal; Santiago Lopez; Julie Stephens; Soledad Fernandez; Mark W Hall; Octavio Ramilo; Asuncion Mejias Journal: J Infect Dis Date: 2012-11-29 Impact factor: 5.226
Authors: A Comas-García; C P López-Pacheco; E A García-Zepeda; G Soldevila; P Ramos-Martínez; J Ramos-Castañeda Journal: Clin Exp Immunol Date: 2016-05-12 Impact factor: 4.330